With over 20 years of experience, Ms. Giroud is widely regarded
as one of the most recognized clinical research and regulatory
experts within the medical device industry - having shared her
extensive knowledge with multi-national corporations and start
up companies from around the globe.
Giroud was the founder and CEO of D-TARGET, a leading clinical
research organization specializing in medical device clinical
trials throughout the European continent.
joined the Premier Research team in July 2007 with the acquisition
of D-TARGET, Ms. Giroud ensured the transition period in the capacity
of VP global strategic development for medical devices until February
Prior to founding D-TARGET, Ms. Giroud has been responsible for
the successful development and implementation of worldwide clinical
research as Director of Clinical Affairs for Collagen Inc.
Medinvent, she handled Trial Management and Product Manager responsibilities
for the product "Wallstent", known as the very first
vascular stent in the world to be placed on the market and now
considered one of the major cardiovascular products.
a Medical Research Associate in the corporate infertility department
for Ares Serono, she coordinated multiple worldwide investigations,
significantly contributing to Serono's placement of the world's
first recombinant hormone for the treatment of female and male
infertility on the market.
highly coveted international speaker, Ms. Giroud is also an active
member of the ISO 14155 task force for the "Clinical investigations
for medical devices and clinical investigation plan" and
serves as a liaison with the Competent Authority medical device
For more information, please contact: